Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cord blood for HIE
NCT02612155Phase 2Completed
- Start
- Mar 2017
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
A Phase 2 trial of autologous umbilical cord blood in hypoxic-ischemic encephalopathy (HIE). Started Mar 2017; status: completed.
02
Drugs
autologous umbilical cord blood
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT02612155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02612155.